Navigation Links
IC Sciences Launches ICS Alliance to Advance Development and Adoption of Informatics Instruments for Next Generation Healthcare
Date:4/2/2008

BOSTON, April 2, 2008 /PRNewswire/ -- IC Sciences Corporation announced today the launch of the company's alliance membership program, ICS Alliance (http://www.icsciencesalliance.com). During the past two years, IC Sciences has been developing components for the newly launched membership program, such as scientific tools, industry products, and market case studies covering healthcare informatics instruments for professional, consumer, and therapeutics medical market sectors. The Alliance program serves as a collaborative nexus of clinicians, healthcare executives, allied professionals, researchers, developers, and other users of these instruments.

Alliance members receive value through a range of program offerings, consisting of a leadership network of experts (Event Series), strategic market analysis and research reports, digital intelligence briefings, and a members-only virtual portal community. Peter M. Nicholas Jr., Founder and Chief Executive Officer of IC Sciences, remarked, "We envision the ICS Alliance as a 'central exchange station' of multi-perspective and multi-sector ideas, tools, practices, and contacts concerning healthcare informatics. We are pleased to be in our second year of the Event Series, which has hosted 18 events and has featured guest hosts such as Clayton Christensen of Harvard Business School, Jonathan Bush of AthenaHealth, and Charlie Baker of Harvard Pilgrim Health. We look forward to inviting the nation's e-health executives, clinicians, and medical informatics leaders to join our membership in 2008 and beyond."

Alliance members, who currently include Revolution Health, AthenaHealth, PatientsLikeMe, and Blue Cross Blue Shield of Massachusetts, joined the program because of a collective interest in understanding this rapidly evolving field, as well as how new sciences and technologies are improving the effectiveness, value, and experience of healthcare. These informatics instruments are used by clinicians, patients, consumers, payers, and therapeutics manufacturers in myriad contexts and applications, including patient engagement, collective intelligence among clinician or patient peers, clinical performance management, and therapeutic product support.

To learn more about ICS Alliance and membership benefits and opportunities, visit http://www.icsciencesalliance.com.

About IC Sciences Corporation

IC Sciences Corporation is a closely held, private organization pioneering in the medical information sciences and informed clinical technology markets. IC Sciences Corporation, through its operating companies, is creating the world's most comprehensive and broadly based developer of intelligent informatics systems and digital informatics instruments for the professional, consumer, and therapeutics medical markets. Our core business is about employing the Internet and related technology platforms to support the delivery of informed clinical systems that optimally impact patient care through the science and the art of contextually differentiated informing. For more information, please visit: http://www.ICSciences.com

Contact:

IC Sciences Corporation

One Joy Street Boston, MA 02108

publicrelations@icsciences.com

1-800-603-1420


'/>"/>
SOURCE IC Sciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
5. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
6. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
7. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
10. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
11. The Pittsburgh Life Sciences Greenhouse Adds New Companies to its Investment Portfolio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings ... mechanism by which its ProCell stem cell therapy ... limb ischemia.  The Company, demonstrated that treatment with ... of limbs saved as compared to standard bone ... molecule HGF resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... ... At its national board meeting in North Carolina, ARCS® Foundation President ... and Astronomy, has been selected for membership in ARCS Alumni Hall of Fame ... Prize in Fundamental physics for the discovery of the accelerating expansion of the universe, ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... medical journal, Epilepsia, Brain Sentinel’s SPEAC® System which uses the surface electromyography ... generalized tonic-clonic seizures (GTCS) using surface electromyography (sEMG). The prospective multicenter phase ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... Hi-C-based genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the ... and accompanying cloud-based bioinformatics software to perform Hi-C metagenome deconvolution using their ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC ... announced that the United States Patent and Trademark Office ... broadly covers the linking of an iris image with ... transaction) and represents the company,s 45 th issued ... patent is very timely given the multi-modal biometric capabilities ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
Breaking Biology News(10 mins):